Monitoring of Biotherapies
Enabling better disease management by measuring serum levels of drugs and anti-drug antibodies (ADA) through an individual approach avoids unnecessary prescriptions.
Whether we are testing cancer drugs, it is essential that clinicians monitor the patient to establish the correct monitoring dose to ensure better compliance and efficacy.
As these are biopharmaceuticals, there is also, in some cases, the effect of immunogenicity. This could in some cases be fatal. Therefore, it is essential to monitor the dosing regimen and immunogenicity of patients taking these drugs. KRISHGEN offers kits in an easy-to-use ELISA format, which are RUO version, CE marked and well validated.
